Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 127-131

  Nomura, Ikuo ^a   Kato, Johji ^b   Tokashiki, Mariko ^a   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Body mass index; Insulin sensitivity; Metabolic disorder

Indexed keywords

ADRENOMEDULLIN; AMMONIA; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; RENIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC DISORDER; MOLECULAR BIOLOGY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENOMEDULLIN; AGED; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; RADIOIMMUNOASSAY; RENIN; TRIGLYCERIDES;

EID: 70349739009     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.08.003     Document Type: Article

References (27)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., and Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192 (1993) 553-560
2. Eto T., Kitamura K., and Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 26 (1999) 371-380
3. Kato J., Tsuruda T., Kitamura K., and Eto T. Adrenomedullin: a possible autocrine or paracrine hormone in the cardiac ventricles. Hypertens Res 26 Suppl (2003) S113-S119
4. Kato J., Tsuruda T., Kita T., Kitamura K., and Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 25 (2005) 2480-2487
5. Shimosawa T., Ogihara T., Matsui H., Asano T., Ando K., and Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 41 (2003) 1080-1085
6. Harmancey R., Senard J.M., Rouet P., Pathak A., and Smih F. Adrenomedullin inhibits adipogenesis under transcriptional control of insulin. Diabetes 56 (2007) 553-563
7. Iemura-Inaba C., Nishikimi T., Akimoto K., Yoshihara F., Minamino N., and Matsuoka H. Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. Am J Physiol Regul Integr Comp Physiol 295 (2008) R1376-R1384
8. Nambu T., Arai H., Komatsu Y., Yasoda A., Moriyama K., Kanamoto N., Itoh H., and Nakao K. Expression of the adrenomedullin gene in adipose tissue. Regul Pept 132 (2005) 17-22
9. Paulmyer-Lacroix O., Desbriere R., Poggi M., Achard V., Alessi M.C., Boudouresque F., Ouafik L., Vuaroqueaux V., Labuhn M., Dutourand A., and Grino M. Expression of adrenomedullin in adipose tissue of lean and obese women. Eur J Endocrinol 155 (2006) 177-185
10. Kitamura K., Ichiki Y., Tanaka M., Kawamoto M., Emura J., Sakakibara S., Kangawa K., Matsuo H., and Eto T. Immunoreactive adrenomedullin in human plasma. FEBS Lett 341 (1994) 288-290
11. Kato J., Kobayashi K., Etoh T., Tanaka M., Kitamura K., Imamura T., Koiwaya Y., Kangawa K., and Eto T. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 81 (1996) 180-183
12. Kato J., Kitamura K., Uemura T., Kuwasako K., Kita T., Kangawa K., and Eto T. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 25 (2002) 887-892
13. Ishimitsu T., Nishikimi T., Saito Y., Kitamura K., Eto T., Kangawa K., Matsuo H., Omae T., and Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94 (1994) 2158-2161
14. Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K., and Eto T. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 244 (1998) 551-555
15. Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for the Study of Obesity: new criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
16. Ohta H., Tsuji T., Asai S., Sasakura K., Teraoka H., Kitamura K., and Kangawa K. One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin Chem 45 (1999) 244-251
17. Ohta H., Tsuji T., Asai S., Tanizaki S., Sasakura K., Teraoka H., Kitamura K., and Kangawa K. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin Chim Acta 287 (1999) 131-143
18. Yamaga J., Hashida S., Kitamura K., Tokashiki M., Aoki T., Inatsu H., Ishikawa N., Kangawa K., Morishita K., and Eto T. Direct measurement of glycine-extended adrenomedullin in plasma and tissue using an ultrasensitive immune complex transfer enzyme immunoassay in rats. Hypertens Res 26 Suppl (2003) S45-S53
19. Hirayama N., Kitamura K., Imamura T., Kato J., Koiwaya Y., and Eto T. Secretion and clearance of the mature form of adrenomedullin in humans. Life Sci 64 (1999) 2505-2509
20. Hirayama N., Kitamura K., Imamura T., Kato J., Koiwaya Y., Tsuji T., Kangawa K., and Eto T. Molecular forms of circulating adrenomedullin in patients with congestive heart failure. J Endocrinol 160 (1999) 297-303
21. Li Y., Totsune K., Takeda K., Furuyama K., Shibahara S., and Takahashi K. Differential expression of adrenomedullin and resistin in 3T3-L1 adipocytes treated with tumor necrosis factor-alpha. Eur J Endocrinol 149 (2003) 231-238
22. Minami J., Nishikimi T., Ishimitsu T., Makino Y., Kawano Y., Takishita S., Kangawa K., and Matsuoka H. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol 36 Suppl 2 (2000) S83-S86
23. Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, Prager G, Ludvik B, Clodi M, Luger A. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity 2009;17:1184-8.
24. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
25. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
26. Ishiyama Y., Kitamura K., Ichiki Y., Sakata J., Kida O., Kangawa K., and Eto T. Haemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 22 (1995) 614-618
27. Cao Y.N., Kitamura K., Ito K., Kato J., Hashida S., Morishita K., and Eto T. Glycine-extended adrenomedullin exerts vasodilator effect through amidation in the rat aorta. Regul Pept 113 (2003) 109-114